A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)

BACKGROUND: The objectives of this study were to build upon previously-reported 12-month findings by retrospectively comparing 24-month follow-up hospitalization charges and potentially-relevant readmissions in US lumbar fusion surgeries that employed either recombinant human bone morphogenetic prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetzell, Bradley, McLean, Julie B., Dorsch, Kimberly, Moore, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600873/
https://www.ncbi.nlm.nih.gov/pubmed/34794470
http://dx.doi.org/10.1186/s13018-021-02829-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600873/
https://www.ncbi.nlm.nih.gov/pubmed/34794470
http://dx.doi.org/10.1186/s13018-021-02829-0

Ejemplares similares